Health testing platform Function inks $450m from General Catalyst
- The capital will enable Function to bring its platform to millions more people faster
- Jonathan Swerdlin serves as co-founder and CEO of Function
- Function was launched in 2023
General Catalyst Partners has provided $450 million in growth financing to Function, a personalized health testing platform.
Function provides access to over 100 blood tests for a yearly subscription.
The capital will enable Function to bring its platform to millions more people faster.
Jonathan Swerdlin serves as co-founder and CEO of Function.
“This financing reflects our belief that Function is one of the defining companies of our generation,” said Pranav Singhvi, partner and co-head of CVF, General Catalyst. “Function has created an entirely new approach to health that we have never had before. We believe Function is uniquely positioned to reach millions more people, and we’re proud to support the next phase of its growth.”
Function was launched in 2023.
